Cobalt has advised US biotech company Biogen on launching its business in Latvia and Estonia.
Biogen is a producer of medicines for the treatment of multiple sclerosis and spinal muscular atrophy, as well as a researcher of solutions for Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis. The company was founded in 1978 and currently employs more than 7400 people worldwide.
Cobalt’s team included, in Latvia, Partner Indrikis Liepa and Associates Marija Berdova, Ivo Maskalans, and Janis Sarans; and in Estonia, Partner Karina Paatsi and Senior Associate Heili Haabu.
